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INTRODUCTION:  A  thoracic  duct  injury  complicated  with  a chylous  ﬁstula  is  a  rather  rare  occurrence  asso-
ciated  with  left  subclavicular  catheterization.  We  present  a new  method  of its  conservative  management
which  seems  to  be  the  least  interventional  described  so  far.  It  can  be  used  in  cases  of  this  iatrogenic  injury
irrespective  of  the  rate  of  chyle  loss.
PRESENTATION OF  CASE:  Our  case  report  involves  a 59-year-old  patient  with  a high-output  chyle  ﬁstula
due  to  left  subclavicular  vein  catheterization,  in  which  biological  cyanoacrylic  glue  was  used  through
percutaneous  infusion  to the  venous  angle,  where  the  thoracic  duct  was  leaking.  An extensive  review  of
the  relevant  literature  is presented.iological glue DISCUSSION: Most  of the  high-output  ﬁstulas  require  a  long  time  of conservative  treatment,  which  may
result  in severe  complications  due  to the  prolongation  of chyle  loss.  An  operation  may  be  needed  in
selected  cases.  Our  proposed  interventional  method  can  be used  in  cases  of percutaneous  injury of  a
chyle  duct,  with  immediate  results.
CONCLUSION: An  iatrogenic  chyle  ﬁstula  due  to left  subclavicular  catheterization  can  be obtained  with  a
percutaneous  injection  of  biological  glue  directly  onto  the  injured  vessel.
gical .© 2012 Sur
. Introduction
The injury of the thoracic duct during the left subclavicular
atheterization is a rare (<1%), but a major complication which
an be fatal if not treated. The chylous ﬁstula created by such
njury, or loss of chyle and lymph into pleural space can lead to
ramatic consequences because of the loss of essential proteins,
mmunoglobulins, fat, vitamins, electrolytes, and water. Larger chy-
othoraces commonly lead to hypovolaemia due to large volume
oss. In the early stages the patient may  not demonstrate clinical
ymptoms or signs of loss of chyle. More complicated cases exhibit
linical features of severe malnutrition. Hyponatraemia, acidosis,
nd hypocalcaemia are the most commonly recognized phenom-
na. Mortality is high in patients with recalcitrant or untreated
hylothorax. The nutritional deﬁciency will continue to persist or
eteriorate unless deﬁnitive therapeutic measures are instituted to
top leakage of chyle through a ﬁstula or into the pleural space.1
The above complications indicate the necessity of early treat-
ent of chyle loss. Some already implemented conservative and
urgical methods will be described. However, in our case report,
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a new conservative management with biological glue, stands as a
unique approach with an effective result, by means of using a very
simple technique.
2.  Case report
A  59-year-old man  was in-patient in the intensive-care unit of
our hospital for supportive treatment of an ischaemic head stroke.
On the 9th day after the introduction of a left subclavicular vein can-
ula, the catheter war  removed because of fever. Instantly a milky,
opalescent ﬂuid started to drain from the puncture of the catheter
at a drainage rate of 50 ml/h (Picture 1). The ﬂuid was  identiﬁed in
the lab as lymph (high fat content in the form of triglycerides). The
patient was initially managed with total parenteral nutrition, con-
sisting of high fat and bowel rest. The ﬂuid started to become more
thin and clear but the drainage volume remained the same. Lym-
phangiography could not be done to demonstrate the exact site of
lymph leak. In this case we could only speculate that the site of the
lymph was  near the left venous junction. From the existing punc-
ture and using the possible anatomic position of the venous angle as
a guide, a needle was  inserted and after a negative blood aspiration,
a slow infusion of 2 ml  cyanoacrylic biological glue was injected in
Open access under CC BY-NC-ND licensethe whole area. After the withdrawal of the needle the drainage of
the lymph was  totally arrested. The chest X-rays were completely
normal in the following days. The patient left the intensive-care
unit in a very good clinical condition.
BY-NC-ND license.
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Picture 1. Chyle was  draining from the puncture site at a rate of 50 ml/h.
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. Discussion
The major function of the thoracic duct is to transport absorbed
at in the form of triglycerides and cholesterol from intestinal lym-
hatics into the venous circulation. The thoracic duct has also an
mportant role in the maintenance of ﬂuid balance and return of
rotein and T lymphocytes to the venous circulation. The most
ommon conﬁguration of the thoracic duct is found in just more
han half of individuals. The thoracic duct arises from the cisterna
hyli at the level of the ﬁrst lumbar vertebra. It ascends through the
bdomen and chest and reaches behind the left subclavian vein as
uch as 3–5 cm above the clavicle. The duct then angles forward
cutely and ends by opening into the posterolateral aspect of the
ngulus venosus, or the junction of the left subclavian and internal
ugular veins (Fig. 1). However, the thoracic duct in rare variations
ay also drain either into the left IJV, or into the left subclavian vein,
he left brachiocephalic vein, or the left external jugular vein. The
ermination is usually within 1 cm from the venous angle. AlmostPEN  ACCESS
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all  thoracic ducts terminate at the posterior or lateral aspect of the
venous structure at or near the angulus venosus. However, termi-
nation of the duct at the anterolateral aspect of the venous angle
has been described.2–4
The management of chyle ﬁstula or chylothorax is either con-
servative or operative, if the conservative methods are proved
ineffective. The therapeutic decision depends on the amount of the
drainage volume. The standard treatment of low-output ﬁstulas is
conservative, and consists of bowel rest, total parenteral nutrition
(TPN) and the administration of somatostatine. There are reports
offering encouraging results by this method,5 as they show a dra-
matic reduction of the lymph leakage in 60–100% of cases after 2–6
weeks of treatment. However in these reports, some patients were
eventually operated on as a ﬁnal resort, in order to control the loss
of chyle. Octreotide can be used instead of somastine, but the results
are not equally encouraging.6
Especially in post-operative chyle ﬁstulas in neck surgery, there
have been reports of cases7 that were successfully treated with
aspiration of the chyle and strapping of the draining area. This type
of management is used only when the surgical incision and skin
ﬂaps remain healthy. It is obvious that strapping cannot be used in
subclavicular injury. However aspirations can be effective in low
drainage ﬁstulas.
Instead  of using total parenteral nutrition (TPN), Lucente et al.8
recommended oral feeding based on special diets. The nutritional
element involves the use of medium chain triglycerides (MCT)
that are easily ingested, rapidly absorbed, and readily metabolized
directly into the portal venous system, bypassing the thoracic duct
lymphatic system.
Percutaneous infusion with povidone-iodine is also described in
the treatment of postoperative cervical chylous lymphocele, based
on its inﬂammatory and sclerosing effects in the subcutaneous area.
Percutaneous catheter drainage in combination with povidone-
iodine infusion has proved to be highly effective in obliterating
lymph leakage after neck surgery.9
Surgical intervention is reserved for cases in which treatment
has failed to halt the chyle loss, or as an early treatment for those
with a high-output ﬁstula.
It has been recommended10 that a reoperation to ligate the tho-
racic duct is necessary if drainage exceeds 1000 ml/day for 7 days.
Additional indications for an operative management, according to
Merrigan et al.11 include: (1) chyle leak greater than 1000 ml/day
for more than 5 days, (2) persistent leak for more than 2 weeks
despite conservative management, (3) nutritional or metabolic
complications, and (4) loculated chylothorax, ﬁbrin clots, or incar-
cerated lung.
Surgical approach is either an open thoracotomy or a video-
assisted-thoracoscopic-surgery (VATS). The operation includes
the ligation of the lymphatic vessel together with all fatty and
ﬁbrous tissues lying between the right azygous vein and the
aorta just above the diaphragm.12 As an additional measure talc
induced pleurodesis may  be used.13 Local injection of tetracy-
cline hydrochloride14 and mediastinal radiotherapy15 has also been
advocated. The use of ﬁbrin glue has been used as an adjunct in
the surgical management of a chyle leak. The glue can be effec-
tively applied on the leaking area during thoracoscopy16 alone
or in combination with thoracic duct ligation.17 In a case of
reoperation for a massive pleural effusion,18 using thoracoscopy,
ﬁbrin glue and an absorbent mesh were used, both of which
were applied to parietal and mediastinal pleura. This method was
selected because of failure to ﬁnd the thoracic duct and the leakage
point.Intravenous administration of an -adrenergic drug such as
etilefrin hydrochloride19 has been shown to be capable of dry-
ing up intra-abdominal lymphatic weeping after resection of the
esophagus en bloc with the thoracic duct.
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A series of adverse reactions have been reported associated with
brin glue application, including hypersensitivity or anaphylactic
eactions, air or gas embolism if the applied pressure is higher than
he recommended by the manufacturer, vascular, skin, subcuta-
eous tissue, cardiac or respiratory disorders, nausea, and ﬂushing
r paresthesia.20
Our method, which involves a percutaneous infusion of biologi-
al glue directly onto the leaking area, is safe, reproducible and easy
o perform. It can be used in any case of chyle ﬁstula, irrespective
f its output capacity.
.  Conclusion
The injury of the thoracic duct complicated with a chylous ﬁs-
ula can be managed conservatively, regardless of the volume of
he drainage, by using biological glue. Even in high volume ﬁstu-
as (>1000 ml/day), the method presented in this article is safe and
ffective, achieving the immediate desired results.
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